Literature DB >> 25244949

Hepatitis C virus core protein suppresses mitophagy by interacting with parkin in the context of mitochondrial depolarization.

Yuichi Hara1, Izumi Yanatori2, Masanori Ikeda3, Emi Kiyokage4, Sohji Nishina1, Yasuyuki Tomiyama1, Kazunori Toida4, Fumio Kishi2, Nobuyuki Kato3, Michio Imamura5, Kazuaki Chayama5, Keisuke Hino6.   

Abstract

Hepatitis C virus (HCV) causes mitochondrial injury and oxidative stress, and impaired mitochondria are selectively eliminated through autophagy-dependent degradation (mitophagy). We investigated whether HCV affects mitophagy in terms of mitochondrial quality control. The effect of HCV on mitophagy was examined using HCV-Japanese fulminant hepatitis-1-infected cells and the uncoupling reagent carbonyl cyanide m-chlorophenylhydrazone as a mitophagy inducer. In addition, liver cells from transgenic mice expressing the HCV polyprotein and human hepatocyte chimeric mice were examined for mitophagy. Translocation of the E3 ubiquitin ligase Parkin to the mitochondria was impaired without a reduction of pentaerythritol tetranitrate-induced kinase 1 activity in the presence of HCV infection both in vitro and in vivo. Coimmunoprecipitation assays revealed that Parkin associated with the HCV core protein. Furthermore, a Yeast Two-Hybrid assay identified a specific interaction between the HCV core protein and an N-terminal Parkin fragment. Silencing Parkin suppressed HCV core protein expression, suggesting a functional role for the interaction between the HCV core protein and Parkin in HCV propagation. The suppressed Parkin translocation to the mitochondria inhibited mitochondrial ubiquitination, decreased the number of mitochondria sequestered in isolation membranes, and reduced autophagic degradation activity. Through a direct interaction with Parkin, the HCV core protein suppressed mitophagy by inhibiting Parkin translocation to the mitochondria. This inhibition may amplify and sustain HCV-induced mitochondrial injury.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25244949     DOI: 10.1016/j.ajpath.2014.07.024

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  Interactions Between Hepatitis C Virus and Mitochondria: Impact on Pathogenesis and Innate Immunity.

Authors:  Ting Wang; Steven A Weinman
Journal:  Curr Pathobiol Rep       Date:  2013-09

Review 2.  Nitric oxide in liver diseases.

Authors:  Yasuko Iwakiri; Moon Young Kim
Journal:  Trends Pharmacol Sci       Date:  2015-05-28       Impact factor: 14.819

Review 3.  Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma.

Authors:  Simonetta Bandiera; C Billie Bian; Yujin Hoshida; Thomas F Baumert; Mirjam B Zeisel
Journal:  Curr Opin Virol       Date:  2016-10-11       Impact factor: 7.121

4.  Mitophagy: therapeutic potentials for liver disease and beyond.

Authors:  Sooyeon Lee; Jae-Sung Kim
Journal:  Toxicol Res       Date:  2014-12

Review 5.  Mitochondrial Proteins Coded by Human Tumor Viruses.

Authors:  Ilaria Cavallari; Gloria Scattolin; Micol Silic-Benussi; Vittoria Raimondi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

Review 6.  PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease.

Authors:  Francois Mouton-Liger; Maxime Jacoupy; Jean-Christophe Corvol; Olga Corti
Journal:  Front Mol Neurosci       Date:  2017-05-01       Impact factor: 5.639

7.  Correlation of hepatitis C virus-mediated endoplasmic reticulum stress with autophagic flux impairment and hepatocarcinogenesis.

Authors:  Yuichi Honma; Koichiro Miyagawa; Yuichi Hara; Tsuguru Hayashi; Masashi Kusanaga; Noriyoshi Ogino; Sota Minami; Shinji Oe; Masanori Ikeda; Keisuke Hino; Masaru Harada
Journal:  Med Mol Morphol       Date:  2021-01-01       Impact factor: 2.309

8.  Mitophagy in TGEV infection counteracts oxidative stress and apoptosis.

Authors:  Liqi Zhu; Chunxiao Mou; Xing Yang; Jian Lin; Qian Yang
Journal:  Oncotarget       Date:  2016-05-10

Review 9.  Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance.

Authors:  Ahmed Atef Mesalam; Koen Vercauteren; Philip Meuleman
Journal:  Viruses       Date:  2016-06-22       Impact factor: 5.048

Review 10.  Viral hepatitis and liver cancer.

Authors:  Marc Ringelhan; Jane A McKeating; Ulrike Protzer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.